Myelodysplastic syndromes;Comprendre pour classer: Les syndromes myélodysplasiques

Revue du Praticien

Volumn 60, Issue 10, 2010, Pages

  Solary, Éric ^a   Fontenay, Michaëla ^b  

^a Universite Paris Sud   (France)

^b Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYELODYSPLASTIC SYNDROME; SHORT SURVEY; ARTICLE; BONE MARROW; CLASSIFICATION; HOSPITALIZATION; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS;

BONE MARROW; HUMANS; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 78651238208     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Mufti GJ, Bennett JM, Goasguen J, et al. Diagnosis and classification of myelodysplastic syndrome: International working group on morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 2008;93:1712-7.
2. Malcovati L, Della Porta MG, Pietra D, et al. Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Blood 2009;114:3538-45.
3. Jädersten M, Hellström-Lindberg E. New clues to the molecular pathogenesis of myelodysplastic syndromes. Exp Cell Res 2010;316:1390-6.
4. Fontenay M, Cathelin S, Amlot M, Gyan E, Solary E. Mitochondria in hematopoiesis and hematological diseases. Oncogene 2006;25:4757-67.
5. Delhommeau F, Dupont S, Della Valle V, et al. Mutation in TET2 in myeloid cancers. N Engl J Med 2009;360:2289-301.
6. Kosmider O, Gelsi-Boyer V, Slama L, et al. Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia 2010;24:1094-6.